Registered entities
AGILE THERAPEUTICS, INC.
Reg. No. 232936302United States
Agile Therapeutics Inc
Reg. No. 1261249United States
AGILE THERAPEUTICS, INC.
Reg. No. 32079858554United States
Agile Therapeutics, Inc.
Reg. No. 20238091233United States
Innovation
17 patent families (13 granted) — focus: Human necessities; filing pace steady. Cited 1,263 times.
| Year | Filings |
|---|---|
| 2013 | 5 |
| 2014 | 6 |
| 2015 | 9 |
| 2016 | 8 |
| 2017 | 7 |
| 2018 | 10 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 6 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 3 |
Investor mix
13 investors on record; lead investors include Investor Growth Capital, Care Capital, ProQuest Investments, Kaiser Permanente Ventures; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 62% |
| Private equity | 3 | 23% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 1 | 8% |